These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 15606054)

  • 21. [Prevention of contrast-induced nephropathy and management of high-risk patients].
    Marenzi G
    G Ital Cardiol (Rome); 2009 Feb; 10(2):88-96. PubMed ID: 19348145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function.
    Nikolsky E; Aymong ED; Dangas G; Mehran R
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S7-S14. PubMed ID: 12556732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of hemofiltration to prevent contrast nephropathy in patients with chronic kidney disease.
    Klarenbach SW; Pannu N; Tonelli MA; Manns BJ
    Crit Care Med; 2006 Apr; 34(4):1044-51. PubMed ID: 16484907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. N-acetylcysteine use to prevent contrast medium-induced nephropathy: premature phase III trials.
    Stenstrom DA; Muldoon LL; Armijo-Medina H; Watnick S; Doolittle ND; Kaufman JA; Peterson DR; Bubalo J; Neuwelt EA
    J Vasc Interv Radiol; 2008 Mar; 19(3):309-18. PubMed ID: 18295688
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics.
    Coyle LC; Rodriguez A; Jeschke RE; Simon-Lee A; Abbott KC; Taylor AJ
    Am Heart J; 2006 May; 151(5):1032.e9-12. PubMed ID: 16644332
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevention of radiocontrast-induced renal insufficiency.
    Shumate MJ
    N Engl J Med; 1995 Apr; 332(15):1035; author reply 1036. PubMed ID: 7885420
    [No Abstract]   [Full Text] [Related]  

  • 27. [The use of acetylcysteine for preventing contrast-induced nephropathy].
    Schaad N; Barghouth G
    Rev Med Suisse; 2005 Jun; 1(25):1693-6. PubMed ID: 16117036
    [No Abstract]   [Full Text] [Related]  

  • 28. N-acetylcysteine versus AScorbic acid for preventing contrast-Induced nephropathy in patients with renal insufficiency undergoing coronary angiography NASPI study-a prospective randomized controlled trial.
    Jo SH; Koo BK; Park JS; Kang HJ; Kim YJ; Kim HL; Chae IH; Choi DJ; Sohn DW; Oh BH; Park YB; Choi YS; Kim HS
    Am Heart J; 2009 Mar; 157(3):576-83. PubMed ID: 19249432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence.
    Bagshaw SM; McAlister FA; Manns BJ; Ghali WA
    Arch Intern Med; 2006 Jan; 166(2):161-6. PubMed ID: 16432083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Contrast medica nephropathy. Better understanding of risk markers and follow up needed].
    Sterner G; Hellström M; Lagerqvist B; Aspelin P; Nyman U
    Lakartidningen; 2009 Jun 24-Jul 7; 106(26-27):1737-42. PubMed ID: 19731735
    [No Abstract]   [Full Text] [Related]  

  • 31. [Nephrotoxic action of contrast media].
    Kleinrok A; Kudyk T
    Przegl Lek; 2005; 62 Suppl 2():57-60. PubMed ID: 16623122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevention of nephrotoxicity induced by radiocontrast agents.
    Barrett BJ; Parfrey PS
    N Engl J Med; 1994 Nov; 331(21):1449-50. PubMed ID: 7969286
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prevention of contrast-induced nephropathy using cardiac catheterization combined with hydration, oral N-acetylcysteine, sodium bicarbonate and iso-osmolar contrast agents].
    Hoshino A; Enomoto S; Kawahito H; Kurata H; Nakahara Y; Nakamura T
    J Cardiol; 2007 Aug; 50(2):119-26. PubMed ID: 17802695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N-acetylcysteine in the prevention of contrast-induced nephropathy.
    Fishbane S
    Clin J Am Soc Nephrol; 2008 Jan; 3(1):281-7. PubMed ID: 18003766
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contrast media nephropathy--how to diagnose and how to prevent?
    Solomon R
    Nephrol Dial Transplant; 2007 Jul; 22(7):1812-5. PubMed ID: 17449491
    [No Abstract]   [Full Text] [Related]  

  • 36. Contrast media nephropathy: in depth review.
    Hussain N; Al Otaibi T; Nampoory MR
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):174-82. PubMed ID: 18310863
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prophylaxis of contrast-induced nephropathy with N-acetylcysteine].
    Gawenda M; Möller A; Wassmer G; Brunkwall J
    Zentralbl Chir; 2007 Jun; 132(3):227-31. PubMed ID: 17610195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast medium-induced nephropathy: strategies for prevention.
    Massicotte A
    Pharmacotherapy; 2008 Sep; 28(9):1140-50. PubMed ID: 18752385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
    Shalansky SJ; Vu T; Pate GE; Levin A; Humphries KH; Webb JG
    Pharmacotherapy; 2005 Aug; 25(8):1095-103. PubMed ID: 16207100
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Editorial: contrast medium-induced nephropathy.
    Persson PB
    Nephrol Dial Transplant; 2005 Feb; 20 Suppl 1():i1. PubMed ID: 15705942
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.